152 related articles for article (PubMed ID: 25755762)
1. Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.
Zhai LL; Cai CY; Wu Y; Tang ZG
Int J Clin Exp Pathol; 2015; 8(1):682-91. PubMed ID: 25755762
[TBL] [Abstract][Full Text] [Related]
2. High-Level Expression and Prognostic Significance of Matrix Metalloprotease-19 and Matrix Metalloprotease-20 in Human Pancreatic Ductal Adenocarcinoma.
Zhai LL; Wu Y; Cai CY; Huang Q; Tang ZG
Pancreas; 2016 Aug; 45(7):1067-72. PubMed ID: 26692439
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
Zhai LL; Wu Y; Cai CY; Tang ZG
Int J Clin Exp Pathol; 2015; 8(6):6919-27. PubMed ID: 26261579
[TBL] [Abstract][Full Text] [Related]
4. [Expression of TFPI-2 gene in pancreatic carcinoma and its prognostic significance].
Tang ZG; Sun ZY; Hu HJ; Xu GL; Chen J; Li JS
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):598-601. PubMed ID: 19102937
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer.
Chen J; Xu H; Zhu XX
Ther Clin Risk Manag; 2016; 12():11-8. PubMed ID: 26730197
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
Med Oncol; 2010 Sep; 27(3):867-75. PubMed ID: 19763915
[TBL] [Abstract][Full Text] [Related]
7. Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.
Zhai LL; Wu Y; Cai CY; Tang ZG
Onco Targets Ther; 2015; 8():2827-34. PubMed ID: 26504399
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed HSPA2 correlates with tumor angiogenesis and unfavorable prognosis in pancreatic carcinoma.
Zhai LL; Xie Q; Zhou CH; Huang DW; Tang ZG; Ju TF
Pancreatology; 2017; 17(3):457-463. PubMed ID: 28416384
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
10. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
Chu X; Zhao P; Lv Y; Liu L
Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
[TBL] [Abstract][Full Text] [Related]
12. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
[TBL] [Abstract][Full Text] [Related]
13. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
14. Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.
Xiang T; Xia X; Yan W
Am J Ther; 2017; 24(4):e431-e434. PubMed ID: 26866436
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
16. Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.
Zhai LL; Wu Y; Huang DW; Tang ZG
Am J Transl Res; 2015; 7(11):2412-22. PubMed ID: 26807187
[TBL] [Abstract][Full Text] [Related]
17. Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer.
Xu C; Wang H; He H; Zheng F; Chen Y; Zhang J; Lin X; Ma D; Zhang H
BMC Cancer; 2013 Mar; 13():118. PubMed ID: 23497249
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of extracellular matrix degrading enzymes-cathepsin L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer.
Singh N; Das P; Datta Gupta S; Sahni P; Pandey RM; Gupta S; Chauhan SS; Saraya A
Cancer Invest; 2013 Aug; 31(7):461-71. PubMed ID: 23915070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
